Downregulation of protein phosphatase-2A (PP2A), which regulates the activity of several Tau kinases and impairs brain glucose metabolism, contributes to abnormal hyperphosphorylation of Tau in AD [158]. This evidence concerns the gene MAPT and Alzheimer disease.